Cargando…

Assessment of Anxiety and Depression Status in Turkish Cutaneous Melanoma Patients

BACKGROUND: Even though anxiety and depression are two mood disorders encountered commonly in cancer patients only few trials have been carried out so far in melanoma patients. The aim of the study was to determine the clinical prevalence of these disorders in Turkish cutaneous melanoma patients and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tas, Faruk, Karabulut, Senem, Guveli, Hulya, Kurul, Sidika, Erturk, Kayhan, Guveli, Murat, Kinik, Hasibe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454729/
https://www.ncbi.nlm.nih.gov/pubmed/28345333
http://dx.doi.org/10.22034/APJCP.2017.18.2.369
_version_ 1783240890064568320
author Tas, Faruk
Karabulut, Senem
Guveli, Hulya
Kurul, Sidika
Erturk, Kayhan
Guveli, Murat
Kinik, Hasibe
author_facet Tas, Faruk
Karabulut, Senem
Guveli, Hulya
Kurul, Sidika
Erturk, Kayhan
Guveli, Murat
Kinik, Hasibe
author_sort Tas, Faruk
collection PubMed
description BACKGROUND: Even though anxiety and depression are two mood disorders encountered commonly in cancer patients only few trials have been carried out so far in melanoma patients. The aim of the study was to determine the clinical prevalence of these disorders in Turkish cutaneous melanoma patients and to clarify possible clinicopathological factors influencing them. MATERIAL AND METHODS: A total of 100 consecutive outpatient melanoma patients were enrolled and asked to complete the Hospital Anxiety and Depression Scale (HADS) questionnaire immediately after scheduled visits. RESULTS: A total of 24 participants had clinical anxiety and 8 were diagnosed with borderline anxiety. Fifteen were diagnosed with clinical depression and 20 with borderline depression. Prior to melanoma diagnosis the majority of the patients, 93 and 86, were assessed as normal in terms of their anxiety and depression status, respectively (p<0.001). A statistically significant correlation was found between anxiety and depression scores (p<0.001). The patients with advanced disease were significantly more anxious and depressive than those with early stage disease. None of the other socio-demographic parameters was found to be correlated with anxiety and depression status. CONCLUSIONS: Because a large group of Turkish melanoma patients, nearly one third of the cohort, was found to be suffering from relevant anxiety and depression, it is of uttermost importance that psychological support and pharmacological intervention for these patients be commenced as soon as possible.
format Online
Article
Text
id pubmed-5454729
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-54547292017-08-28 Assessment of Anxiety and Depression Status in Turkish Cutaneous Melanoma Patients Tas, Faruk Karabulut, Senem Guveli, Hulya Kurul, Sidika Erturk, Kayhan Guveli, Murat Kinik, Hasibe Asian Pac J Cancer Prev Research Article BACKGROUND: Even though anxiety and depression are two mood disorders encountered commonly in cancer patients only few trials have been carried out so far in melanoma patients. The aim of the study was to determine the clinical prevalence of these disorders in Turkish cutaneous melanoma patients and to clarify possible clinicopathological factors influencing them. MATERIAL AND METHODS: A total of 100 consecutive outpatient melanoma patients were enrolled and asked to complete the Hospital Anxiety and Depression Scale (HADS) questionnaire immediately after scheduled visits. RESULTS: A total of 24 participants had clinical anxiety and 8 were diagnosed with borderline anxiety. Fifteen were diagnosed with clinical depression and 20 with borderline depression. Prior to melanoma diagnosis the majority of the patients, 93 and 86, were assessed as normal in terms of their anxiety and depression status, respectively (p<0.001). A statistically significant correlation was found between anxiety and depression scores (p<0.001). The patients with advanced disease were significantly more anxious and depressive than those with early stage disease. None of the other socio-demographic parameters was found to be correlated with anxiety and depression status. CONCLUSIONS: Because a large group of Turkish melanoma patients, nearly one third of the cohort, was found to be suffering from relevant anxiety and depression, it is of uttermost importance that psychological support and pharmacological intervention for these patients be commenced as soon as possible. West Asia Organization for Cancer Prevention 2017 /pmc/articles/PMC5454729/ /pubmed/28345333 http://dx.doi.org/10.22034/APJCP.2017.18.2.369 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Research Article
Tas, Faruk
Karabulut, Senem
Guveli, Hulya
Kurul, Sidika
Erturk, Kayhan
Guveli, Murat
Kinik, Hasibe
Assessment of Anxiety and Depression Status in Turkish Cutaneous Melanoma Patients
title Assessment of Anxiety and Depression Status in Turkish Cutaneous Melanoma Patients
title_full Assessment of Anxiety and Depression Status in Turkish Cutaneous Melanoma Patients
title_fullStr Assessment of Anxiety and Depression Status in Turkish Cutaneous Melanoma Patients
title_full_unstemmed Assessment of Anxiety and Depression Status in Turkish Cutaneous Melanoma Patients
title_short Assessment of Anxiety and Depression Status in Turkish Cutaneous Melanoma Patients
title_sort assessment of anxiety and depression status in turkish cutaneous melanoma patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454729/
https://www.ncbi.nlm.nih.gov/pubmed/28345333
http://dx.doi.org/10.22034/APJCP.2017.18.2.369
work_keys_str_mv AT tasfaruk assessmentofanxietyanddepressionstatusinturkishcutaneousmelanomapatients
AT karabulutsenem assessmentofanxietyanddepressionstatusinturkishcutaneousmelanomapatients
AT guvelihulya assessmentofanxietyanddepressionstatusinturkishcutaneousmelanomapatients
AT kurulsidika assessmentofanxietyanddepressionstatusinturkishcutaneousmelanomapatients
AT erturkkayhan assessmentofanxietyanddepressionstatusinturkishcutaneousmelanomapatients
AT guvelimurat assessmentofanxietyanddepressionstatusinturkishcutaneousmelanomapatients
AT kinikhasibe assessmentofanxietyanddepressionstatusinturkishcutaneousmelanomapatients